Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
An ion channel hypothesis to explain divergent cardiovascular safety of COX-2 inhibitors: the answer to a hotly-debated puzzle
Molecular Pharmacology, 08/05/09
Shapiro MS et al. – This Perspective discusses these findings in light of the role of KCNQ K+ channels in control of excitability in general, the "lipid imbalance theory" of COX–2 risks, and the potential for novel therapeutic modalities for cardiovascular disease focused on ion channels in vascular smooth muscle.
Related Articles
Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study
Arthritis & Rheumatism, 11/05/09
Relevance Score: 94%
Physical Activity and Prevention of Cardiovascular Disease in Older Adults
Clinics in Geriatric Medicine, 12/01/09
Relevance Score: 92%
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy, 11/16/09
Relevance Score: 91%
Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence?
Women's Health, 11/02/09
Relevance Score: 91%
Diabetes and Cardiovascular Disease Prevention in Older Adults
Clinics in Geriatric Medicine, 12/01/09
Relevance Score: 90%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
Current Medical Research and Opinion, 12/18/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


